Bachem Wins Deal to Manufacture Peptide APIs for Axon
Axon has chosen Swiss CMO Bachem to manufacture the peptide API and finished form for its clinical trials.
Archives for April 9, 2013
Crown and Horizon Team on Preclinical Model Development for Personalized Meds
Crown Bioscience and Horizon Discovery have teamed up to develop more accurate preclinical models for the development of personalized medicines.
Client Demand Pushes Early Phase Australian CRO to Expand to Large Molecules
Early phase clinical trial provider CPR Pharma Services has expanded its bioanalytical offerings with a ligand-binding assay service for its clients developing large molecules such as biologics, monoclonal antibodies and biosimilars.